Pharmacogenomics
Explore how your unique DNA dictates your response to medications. At London Genetics, we eliminate the dangerous trial-and-error approach to prescribing, replacing it with targeted genetic precision to find the exact drug, compatibility, and dosage for your body.
What Is Pharmacogenomics?
The Dissolution of the “One-Size-Fits-All” Paradigm
For generations, clinical medicine has operated under a standardised prescribing model: if a patient is diagnosed with a specific condition, they are routinely prescribed a standardised pharmaceutical compound at a predetermined, generic dosage. However, human biology is far too intricate for such a simplistic approach. This is where the clinical discipline of pharmacogenomics intervenes, fundamentally redefining how we select and administer therapeutic treatments.
At its core, pharmacogenomics is the scientific study of how an individual’s unique genetic architecture influences their physiological response to medications. By examining subtle variations within your DNA, clinical geneticists can bypass the traditional, often disheartening process of clinical trial and error. Instead of hoping a medication will work, we can now look directly at your genetic code to determine its suitability beforehand.
How Genomic Variations Dictate Drug Response
Every medication you ingest undergoes a complex journey through your body. It must be absorbed, transported to the target site, metabolised, and eventually excreted. This entire process is regulated by specific proteins and enzymes, which are produced based on instructions written in your DNA.
When we perform a pharmacogenomics assessment, we look for variations in these critical genes:
Enzymatic Activity and Metabolism: The Cytochrome P450 (CYP450) gene family in the liver is responsible for processing the vast majority of modern pharmaceuticals. Variations in these genes can classify you as a poor, intermediate, or ultra-rapid metaboliser, directly affecting how long a drug stays in your system.
Receptor Compatibility: Some genetic variations alter the structure of cell receptors, meaning a drug may fail to bind effectively, rendering the treatment entirely useless despite a correct diagnosis.
Toxicity and Adverse Events: By identifying specific genomic markers, pharmacogenomics can pinpoint if you carry a heightened sensitivity to certain chemical compounds, allowing us to proactively avoid severe adverse drug reactions.
A Lifelong Asset for Clinical Decision-Making
The clinical utility of a pharmacogenomics profile extends far beyond solving an immediate medical puzzle. Because your core DNA sequence remains completely unchanged throughout your lifetime, the data gathered from a single genetic test serves as a permanent clinical companion. Whether you require cardiovascular support, psychiatric intervention, or pain management decades from now, your healthcare providers will possess a precise, objective map to prescribe the correct medication, at the optimum dose, from the very first day of treatment.
Who Should Consider Pharmacogenomic Testing?
While anyone looking to take proactive control of their healthcare can benefit from understanding their genetic makeup, pharmacogenomic testing is particularly vital for individuals navigating complex clinical challenges. By identifying your unique genetic variants, this analysis provides an objective roadmap to help you and your physicians make informed, safe, and highly personalised treatment decisions.
If you have experienced severe or unexpected side effects from standard drug doses, your body may be processing the compound abnormally. Testing pinpoints exactly how your liver enzymes or cellular receptors react, allowing clinicians to safely adjust dosages or select well-tolerated alternatives.
Many patients spend years on frustrating trial-and-error prescriptions, particularly for psychiatric, cardiovascular, or chronic pain therapies. A pharmacogenomics assessment reveals if you are rapidly metabolising drugs before they can work, or if your cellular receptors are inherently incompatible with them.
Managing multiple medications simultaneously introduces a high risk of drug-to-drug interactions that can congest liver metabolic pathways. Testing evaluates your genetic compatibility across multiple compounds, helping your clinical team rationalise prescriptions and reduce cumulative drug burdens.
In fields such as oncology and cardiology, the therapeutic window between an effective dose and a highly toxic one is exceptionally narrow. Pre-treatment profiling ensures your body can safely tolerate and benefit from critical, high-risk therapies like chemotherapy or advanced blood thinners.
You do not need to be currently unwell to benefit from this technology. Undergoing testing as a one-time preventative measure ensures that if you ever require urgent cardiovascular support, pain management, or acute care, your medical team will already possess the exact blueprint to treat you safely.
Personalised medicine for safer healthcare. Aligning advanced molecular diagnostics with your everyday prescriptions eliminates the clinical trial-and-error cycle, providing ultimate therapeutic precision and long-term peace of mind.
What Medications Can Pharmacogenomic Testing Assess
The clinical application of genomic medicine is highly specialised. Rather than looking at your genetic profile in isolation, we categorise our testing into distinct medical clusters. This ensures that the genetic data we extract is directly applicable to the specific medical fields where medication management is most critical.
1. Psychiatric Pharmacogenetics | Mental Health Precision
Treating mental health conditions has historically been one of the most trial-and-error-prone areas of medicine. Finding the right antidepressant, antipsychotic, or mood stabiliser can take months of distressing experimentation, during which patients must endure both the symptoms of their condition and the side effects of incompatible drugs.
With psychiatric pharmacogenetics, we evaluate the specific genetic pathways that govern how your brain and liver interact with psychiatric compounds.
Predicting Antidepressant Response: We analyze the genes that dictate the transport of neurotransmitters, predicting whether a specific class of drugs (such as SSRIs or SNRIs) is likely to be effective.
Avoiding Severe Side Effects: Our testing identifies genetic profiles prone to severe side effects—such as extreme sedation, rapid weight gain, or heightened anxiety—allowing your psychiatrist to prescribe with absolute confidence from the very first consultation.
2. Cardiovascular Drug Response Testing | Heart Care Alignment
For heart patients, prescribing accuracy is not just a matter of comfort; it is a matter of critical safety. Medications such as blood thinners (anticoagulants), beta-blockers, and cholesterol-lowering statins have incredibly narrow therapeutic windows, meaning the difference between a life-saving dose and a toxic one is dangerously small.
Cardiovascular drug response testing ensures your cardiac regimen is perfectly aligned with your DNA:
Preventing Blood Clots and Bleeding: Genetic variations can make drugs like clopidogrel or warfarin virtually ineffective in some patients, while causing dangerous bleeding risks in others. We verify your metabolic compatibility to prevent these outcomes.
Eliminating Statin-Induced Muscle Pain: Many patients discontinue vital cholesterol treatments due to severe muscle pain. Testing identifies if you carry the genetic markers that make you susceptible to statin intolerance, helping us select a compound your body can tolerate.
3. Oncology Pharmacogenomics | Targeted Cancer Care
Oncology has shifted entirely away from general chemotherapy toward highly targeted precision medicine. Cancer treatments are incredibly powerful, and ensuring that a patient’s body can safely process these therapeutic agents is vital to preserving their strength and maximizing their survival rates.
Through oncology pharmacogenomics, we examine the genetic relationship between your healthy tissues and potential cancer therapies:
Mitigating Severe Chemotherapy Toxicity: Certain inherited genetic deficiencies (such as a DPD deficiency) make standard chemotherapy doses highly toxic and potentially life-threatening. Pre-screening identifies these rare vulnerabilities so your oncologist can adjust the dosage or choose an alternative drug.
Enhancing Treatment Efficacy: By aligning the chemotherapy protocol with your systemic metabolic profile, we help ensure your body has the strength to complete the full treatment cycle without unnecessary delays.
4. Personalized Drug Dosing & Metabolism Mapping
Your liver contains a massive system of enzymes, primarily the Cytochrome P450 (CYP450) family, tasked with breaking down almost every foreign substance you ingest. How these enzymes are structured—and how quickly they work—is determined entirely by your genetics.
Through comprehensive metabolism mapping, we place you into one of four distinct genetic categories to guide precise dosing:
Poor Metabilisers: Your enzymes process drugs exceptionally slowly. Standard doses can build up in your bloodstream, leading to toxic accumulations and severe side effects. You require much lower doses or completely different drugs.
Intermediate Metabilisers: Your rate of clearance is slightly reduced, often requiring subtle dosage calibrations to prevent long-term side effects.
Normal (Extensive) Metabilisers: Your body processes medications at the standard expected rate, meaning you can safely utilize traditional clinical dosing guidelines.
Ultra-Rapid Metabilisers: Your liver clears medications almost instantly. Standard doses are destroyed before they can even enter your system, rendering the treatment useless. You require significantly higher doses or alternative delivery methods.
Pharmacogenomic Testing for Cardiovascular Medications
Pharmacogenomics has revolutionised how we understand cardiovascular drug response. Genetic variations can significantly influence how patients metabolise medications such as blood thinners, beta-blockers, and statins. These differences determine the efficacy and safety of treatments, making genetic insights essential for optimising cardiovascular care.
Importance of Tailored Treatments for Heart Patients
For heart patients, receiving the correct medication at the right dose is vital. Tailored treatments based on genetic testing reduce the risk of adverse drug reactions and improve therapeutic outcomes. personalised cardiovascular drug response testing ensures that patients receive therapies suited specifically to their genetic profile, enhancing both safety and effectiveness.
Cutting-edge Testing Facilities
London is home to some of the most advanced pharmacogenomics testing facilities worldwide. These centres combine innovative technology with expert clinical knowledge to provide comprehensive cardiovascular drug response testing. Patients across London benefit from access to these services, which support personalised treatment plans that improve heart health outcomes.
Oncology Pharmacogenomics
Pharmacogenomics is transforming oncology by enabling personalised cancer treatments tailored to an individual’s genetic profile. By analysing the genetic mutations within both the patient and their tumour, clinicians can select therapies that are more likely to be effective, while minimising harmful side effects. This precision medicine approach is improving survival rates and quality of life for cancer patients.
London is at the forefront of oncology pharmacogenomics research and clinical application. Leading hospitals and research centres in the city are pioneering new genetic testing methods and targeted therapies. These advances allow for more accurate prediction of drug response and resistance, helping oncologists develop bespoke treatment plans that maximise benefit and reduce toxicity.
Numerous success stories from London highlight the impact of pharmacogenomics in cancer care. Patients who previously had limited treatment options have experienced remarkable improvements due to tailored therapies informed by genetic testing. These case studies not only demonstrate the promise of oncology pharmacogenomics but also solidify London’s reputation as a centre of excellence in personalised cancer treatment.
Precision oncology at its best. London’s cutting-edge pharmacogenomics programmes offer hope and improved outcomes for cancer patients through tailored genetic-based treatments.
How Pharmacogenomic Testing Works
Streamlining Your Path to Personalised Healthcare
Embarking on a journey toward genetics-guided medicine is a straightforward, entirely non-invasive process. At London Genetics, we have designed our clinical pathway to be as seamless and supportive as possible, ensuring you transition from clinical uncertainty to absolute therapeutic clarity without any unnecessary stress.
By integrating pharmacogenomics into your routine care, we provide you and your physicians with a clear, reliable, and scientifically validated roadmap to guide your prescribing decisions.
The Four Steps of Our Clinical Process
Step 1: Your Initial Consultation
Your journey begins with a private consultation with our specialist clinical geneticist, Dr Ehsan Karimiani. During this initial discussion, we will review your personal medical history, your current medication regimen, and any previous adverse drug reactions you may have experienced. This allows us to select the precise pharmacogenomics panel that best aligns with your immediate health needs and long-term wellness goals.
Step 2: Simple and Non-Invasive Sample Collection
Once your specific testing panel is confirmed, we collect your DNA sample. This process is entirely painless and takes less than ten minutes to complete. In most cases, a simple, non-invasive cheek swab (buccal swab) is all that is required to gather enough cellular material for analysis. If a comprehensive multi-panel test is needed, a standard, routine blood draw can also be arranged at our state-of-the-art London facility.
Step 3: Advanced Laboratory Analysis
Your sample is then processed using next-generation sequencing (NGS) within our highly regulated laboratory environment. Our clinical specialists meticulously analyse your DNA, looking specifically at the genes responsible for drug transport, receptor compatibility, and liver enzyme metabolism—such as the Cytochrome P450 family. This technical scan determines exactly how your body is programmed to interact with hundreds of common medications.
Step 4: Expert Interpretation and Your Lifetime Portfolio
Once your analysis is complete, you will attend a follow-up consultation to review your results. We translate the complex genomic data into a clear, colour-coded, and highly practical report. You will receive a permanent digital and physical copy of this medical portfolio. Because your genetic blueprint does not change, this report remains a lifelong clinical asset that you can share with any GP, consultant, or pharmacist to guarantee safe, optimised prescriptions for the rest of your life.
What Your Pharmacogenomic Results Will Show
Transitioning from clinical speculation to diagnostic certainty allows you to reclaim direct control over your healthcare plan, replacing traditional trial-and-error medicine with data-driven recovery pathways.
Hover over each box for more detailed information!
A new era in personalised medicine. Integrating your unique pharmacogenomic profile into everyday clinical care delivers safer, highly predictable medical outcomes and an unshakeable foundation for lifelong health.
Why Choose London Genetics?
Uncompromising Expertise in Clinical Genetics
When choosing a provider for genetic analysis, the clinical credentials of the team overseeing your care are paramount. Unlike general wellness clinics or commercial direct-to-consumer testing companies, London Genetics is a highly specialised medical practice. Your DNA sample is not simply run through a basic software algorithm; it is meticulously reviewed, interpreted, and integrated into your healthcare strategy by leading specialists, including our clinical geneticist Dr Ehsan Karimiani. This ensures your pharmacogenomics data is clinically actionable, meeting the stringent standards required by top consultants and physicians worldwide.
Why Our Clinical Approach Stands Apart
Consultative, Specialist-Led Care: We do not believe in sending patients a complex, confusing PDF report to decipher on their own. Every genetic test we conduct includes pre- and post-test consultations, ensuring you fully understand how your unique genetic profile influences your past, present, and future treatments.
Next-Generation Genomic Technology: We utilise the most advanced next-generation sequencing (NGS) platforms available in the UK. This state-of-the-art diagnostic technology allows us to map your genetic metabolic pathways with absolute precision, offering an incredibly high degree of accuracy that basic testing kits simply cannot match.
A Lifelong, Seamless Health Asset: The report we compile for you is designed to be highly practical and immediately usable by any healthcare professional. We present your results in an intuitive, colour-coded format that easily integrates into your medical records, providing a permanent shield against adverse drug reactions wherever you receive treatment.
An Empathetic, Patient-First Environment: Navigating health challenges and medication changes can be deeply stressful. At our London facility, we combine cutting-edge science with a warm, supportive, and private clinical experience, giving you the time, reassurance, and clarity you deserve on your journey toward better health.
The Clinical Impact of Pharmacogenomic Testing
Evidence-Based Results for Safer and More Effective Prescribing
While the science of pharmacogenomics sounds highly advanced on paper, its true value is measured by the profound impact it has on real human lives. For decades, medicine has accepted a certain rate of treatment failure and drug toxicity as an unavoidable cost of healthcare. Precision medicine changes this entirely, turning clinical guesswork into a highly predictable, preventative discipline.
Across the UK and Europe, the clinical integration of pharmacogenomics is actively restructuring how doctors prescribe, saving patients from months of unnecessary suffering and protecting them from severe, systemic health crises.
Key Evidence: What the Clinical Data Shows
To understand the scale of safety and efficacy that pharmacogenomics introduces, we only need to look at the latest large-scale clinical evidence:
A 30% Reduction in Severe Side Effects: Landmark European multicentre clinical trials (such as the PREPARE trial) have demonstrated that preemptively testing patients with a standard pharmacogenetic panel leads to an immediate 30% reduction in clinically significant adverse drug reactions (ADRs) and subsequent hospitalisations.
Preventing the Most Common Drug Reactions: Recent genomic analyses of UK healthcare registries show that up to 1 in 11 reported medication side effects could be entirely avoided. Remarkably, just three metabolic genes—CYP2C19, CYP2D6, and SLCO1B1—account for 75% of all genetically linked adverse drug reactions, particularly within cardiovascular, psychiatric, and pain management pathways.
A Crucial Safety Net for Mental Health: Psychiatric medications are statistically overrepresented in severe side effect reports. Clinical evidence reveals that pre-emptive pharmacogenomics testing could prevent nearly 30% of these debilitating mental health prescription failures, completely transforming the safety profile of psychiatric care.
The Real-World Impact on Patients
In practice, these statistics translate into life-changing clinical outcomes. Instead of enduring weeks of debilitating nausea, severe fatigue, or dangerous heart arrhythmias while waiting to see if a blood pressure medication or antidepressant is working, patients treated under a pharmacogenomics framework bypass these risks entirely.
By identifying your genetic metabolic limits before your treatment begins, your clinical team can confidently select the exact compound and precise dosage your body is biochemically programmed to accept. This represents the absolute pinnacle of modern, patient-first preventative medicine—ensuring your path to recovery is both exceptionally safe and incredibly fast.
The Future of Pharmacogenomics
The future of pharmacogenomics looks incredibly promising. As technology advances and research deepens, personalised medicine will become more accessible and precise, leading to better health outcomes for all patients across the city.
By harnessing the power of genetic information, patients are empowered to take control of their treatment journey. Pharmacogenomics enables safer, more effective therapies tailored specifically to each individual’s genetic makeup, transforming healthcare from reactive to proactive.
Ready to embrace personalised medicine? Book a consultation with our pharmacogenomics specialists today and take the next step towards safer, more effective treatments.
Book a Consultation
Dr Ehsan Karimiani
In this section you can check frequently asked questions.
What is pharmacogenomics and why is it important in London?
Pharmacogenomics is the study of how genes affect a person’s response to drugs. In London, this science is transforming healthcare by enabling personalised medicine, helping doctors prescribe the most effective and safest medications based on your genetic profile.
How does pharmacogenomic testing work at London Genetics?
Testing involves a simple, non-invasive sample collection, usually a saliva or blood test. The sample is analysed using advanced genetic technologies available in London, and results guide doctors in selecting the best medications for you.
Which conditions can pharmacogenomics help with?
Pharmacogenomics is particularly useful for mental health disorders, cardiovascular diseases, cancer treatments, and many other conditions where medication response varies between individuals.
How long does it take to get results from pharmacogenomic testing in London?
Typically, results are available within 1 to 3 weeks, depending on the specific test. London’s advanced labs strive to provide prompt and accurate results to support timely treatment decisions.
Does a pharmacogenomic test need to be repeated as I age?
No. Unlike routine blood tests that monitor fluctuating biomarkers, your fundamental DNA sequence remains entirely constant throughout your life. This makes pharmacogenomics a one-time clinical investment. The detailed genomic blueprint we generate for you today will remain just as accurate and valuable decades from now, serving as a permanent guide for any future prescriptions.
Can pharmacogenomics help adjust the doses of medications I am already taking?
Absolutely. If you are currently struggling with persistent side effects or feel your current treatment is failing, a pharmacogenomics profile can pinpoint the exact metabolic cause. By mapping your liver enzymes, our specialists can determine if your body is clearing a drug too quickly (making it ineffective) or too slowly (causing toxic build-up), allowing your physician to safely recalibrate your dose.
How secure is my genetic data during and after testing?
We maintain the absolute highest standards of medical confidentiality and data privacy. Your genomic sample is processed in state-of-the-art, highly regulated laboratory facilities strictly adhering to UK data protection laws. Your pharmacogenomics results are strictly confidential; they are shared only with you and, with your explicit consent, your designated healthcare providers. We never share or sell genetic data to third parties or insurance companies.
Are all prescription medications covered by a pharmacogenomics panel?
While pharmacogenomics covers a vast majority of the world’s most commonly prescribed medications, not every single pharmaceutical has a known genetic link. Some drugs are processed by the body through pathways that do not rely heavily on genetically variable enzymes. During your initial consultation, we will review your current prescriptions to ensure they align with the specific genes we can actively test.
Medication Compatibility Testing
Medication Compatibility Testing is all about understanding whether the medicines you take are truly the right fit for your body.
Psychiatric Pharmacogenetics
Psychiatric Pharmacogenetics is the study of how an individual’s genetic profile influences their response to psychiatric medications such as antidepressants, antipsychotics, and mood stabilisers.
Oncology Pharmacogenomics
Oncology and pharmacogenomics may sound like highly technical terms, but together they represent one of the most exciting advances in modern medicine. Oncology is the branch of medicine dedicated to the study
Personalized Drug Dosing Based on Genetics
Personalised medicine, often referred to as precision medicine, is an approach to healthcare that tailors treatment to the unique characteristics of each individual. Rather than applying a ‘one-size-fits-all’ model, it considers factors such as genetics, environment, and lifestyle to optimise outcomes.
Cardiovascular Drug Response Testing
Cardiovascular disease (CVD) remains the leading cause of illness and death worldwide, placing a significant burden on individuals, families, and healthcare systems.
I’ve been on psychiatric meds for years and always had side effects. Can this test actually save me from the usual trial and error?
Yes, Markus. By checking your genetic profile, we can often predict how you’ll react to certain meds. That way, we can avoid the long guesswork and get you on the right treatment faster.
I just had my pharmacogenomic test done here and I’m a bit nervous. Can it really help me know which antidepressant will work best?
Absolutely, Hannah. These tests look at your genes to see how your body might respond to different antidepressants. It’s not magic, but it really helps us choose the right medication and dose for you, so side effects are less likely.
How long does it usually take to get the test results?
Typically about 1–3 weeks, Layla. Once the results are in, we’ll go through them together and adjust your treatment accordingly. It’s quick and really useful for personalised care.